2023
DOI: 10.1007/978-3-031-32997-5_7
|View full text |Cite
|
Sign up to set email alerts
|

Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 255 publications
0
1
0
Order By: Relevance
“…Other scientists employed several biomarkers to evaluate the effects of the treatment strategy on brain pathology and neuroprotection. [ 57 ] The study focused on biomarkers associated with Alzheimer’s disease, including amyloid beta peptide and phosphorylated tau, both of which are key players in the pathological process. In addition, the study likely assessed markers of inflammation, oxidative stress, and neuronal damage to understand the broader impact of the treatment.…”
Section: Evaluating Neuroprotection Outcomesmentioning
confidence: 99%
“…Other scientists employed several biomarkers to evaluate the effects of the treatment strategy on brain pathology and neuroprotection. [ 57 ] The study focused on biomarkers associated with Alzheimer’s disease, including amyloid beta peptide and phosphorylated tau, both of which are key players in the pathological process. In addition, the study likely assessed markers of inflammation, oxidative stress, and neuronal damage to understand the broader impact of the treatment.…”
Section: Evaluating Neuroprotection Outcomesmentioning
confidence: 99%